Exploiting the Potential of Neural Attentional Control to Overcome Hearing Impairment (NeurAttContr)
Hearing Loss, Attention Impaired, Tinnitus
About this trial
This is an interventional basic science trial for Hearing Loss focused on measuring neuromodulation, auditory attention, neurobiology of language, electroencephalography, transcranial alternating current stimulation, neurofeedback, alpha oscillations, speech tracking
Eligibility Criteria
Inclusion Criteria:
- Age: 18-35 / 55-75
- German as first language
- Normal or corrected to normal vision
- Right-handed
- Normal hearing, hearing impairment or tinnitus (see specified inclusion)
- Normal hearing: ≤20 decibel (dB) hearing level (HL) at frequencies from 250 Hz to 8,000 Hz for both ears.
Specified inclusion for Experiment 1, 2, 3 & 4:
- Hearing loss:
- bilateral symmetrical sensorineural hearing loss
- pure tone thresholds of ≥25 dB HL at one or more frequencies between 250 Hz and 8,000 Hz and differences in thresholds across the two ears of ≤20 dB at every frequency.
- Tinnitus:
- Persistent chronic tinnitus with duration of more than 3 months
- Tinnitus with a Tinnitus Handicap Inventory Grade 2 to 4 (18-76 points)
Exclusion Criteria:
- Non-symmetrical hearing loss
- Raised bi- or multilingually (second language acquired earlier than 6 years of age)
- Women who are currently pregnant or breastfeeding
History of brain injury or any neurological disorder (y/n)
• For example, stroke, traumatic brain injury, brain surgery, epilepsy etc.
- Dyslexia
- History of psychiatric disorder
- Recent recreational drug consumption
- Known or suspected drug or alcohol abuse
- Medication with cognitive side effects (e.g., psychoactive medications or sleeping pills)
- Metallic implants in the head region (excluding fixed braces and tooth fillings)
- Any implanted medical device (e.g., cardiac pacemakers)
- Previous enrolment in one of the experiments comprising the main investigational plan
Sites / Locations
- University of Zurich
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Arm 5
Arm 6
Arm 7
Arm 8
Arm 9
Arm 10
Arm 11
Arm 12
Arm 13
Arm 14
Arm 15
Arm 16
Arm 17
Arm 18
Arm 19
No Intervention
No Intervention
No Intervention
No Intervention
No Intervention
Experimental
Sham Comparator
Experimental
Sham Comparator
Experimental
Sham Comparator
Experimental
Sham Comparator
Experimental
Sham Comparator
Experimental
Sham Comparator
Experimental
Active Comparator
Experiment 1 - Normal hearing - AAT
Experiment 1 - Hearing impaired - AAT
Experiment 2 - normal hearing _ SAT
Experiment 2 - hearing impaired - SAT
Experiment 2 - tinnitus - SAT
Experiment 3 - normal hearing (tACS) - AAT
Experiment 3 - normal hearing (sham) - AAT
Experiment 3 - hearing impaired (tACS) - AAT
Experiment 3 - hearing impaired (sham) - AAT
Experiment 3 - tinnitus (tACS) - AAT
Experiment 3 - tinnitus (sham) - AAT
Experiment 4 - normal hearing (tACS) - SAT
Experiment 4 - normal hearing (sham) - SAT
Experiment 4 - hearing impaired (tACS) - SAT
Experiment 4 - hearing impaired (sham) - SAT
Experiment 4 - tinnitus (tACS) - SAT
Experiment 4 - tinnitus (sham) - SAT
Experiment 5 - normal hearing (NF right) - AAT
Experiment 5 - normal hearing (NF left) - AAT
Each participant assigned to the normal hearing group will undergo one experimental session during which EEG is recorded while participants perform an auditory attention task (AAT).
Each participant assigned to the normal hearing impaired group will undergo one experimental session during which EEG is recorded while participants perform an auditory attention task (AAT).
Each participant assigned to the normal hearing group will undergo one experimental session in which EEG is used to measure neural speech tracking while participants undergo the selective speech attention task (SAT).
Each participant assigned to the hearing impaired group will undergo one experimental session in which EEG is used to measure neural speech tracking while participants undergo the selective speech attention task (SAT).
Each participant assigned to the tinnitus group will undergo one experimental session in which EEG is used to measure neural speech tracking while participants undergo the selective speech attention task (SAT).
The subjects assigned to the normal hearing group will undertake 20min tACS stimulation applied over the temporo-parietal cortex. Each session will include the following three phases: (1) pre-stimulation baseline, (2) brain stimulation, and (3) post-stimulation. AAT will be conducted in each phase and concurrent EEG will be recorded.
The subjects assigned to the normal hearing group will undertake 20min sham stimulation applied over the temporo-parietal cortex. Each session will include the following three phases: (1) pre-stimulation baseline, (2) sham brain stimulation, and (3) post-stimulation. AAT will be conducted in each phase and concurrent EEG will be recorded.
The subjects assigned to the hearing impaired group will undertake 20min tACS stimulation applied over the temporo-parietal cortex. Each session will include the following three phases: (1) pre-stimulation baseline, (2) brain stimulation, and (3) post-stimulation. AAT will be conducted in each phase and concurrent EEG will be recorded.
The subjects assigned to the hearing impaired group will undertake 20min sham stimulation applied over the temporo-parietal cortex. Each session will include the following three phases: (1) pre-stimulation baseline, (2) sham brain stimulation, and (3) post-stimulation. AAT will be conducted in each phase and concurrent EEG will be recorded.
The subjects assigned to the tinnitus group will undertake 20min tACS stimulation applied over the temporo-parietal cortex. Each session will include the following three phases: (1) pre-stimulation baseline, (2) brain stimulation, and (3) post-stimulation. AAT will be conducted in each phase and concurrent EEG will be recorded.
The subjects assigned to the tinnitus group will undertake 20min sham stimulation applied over the temporo-parietal cortex. Each session will include the following three phases: (1) pre-stimulation baseline, (2) sham brain stimulation, and (3) post-stimulation. AAT will be conducted in each phase and concurrent EEG will be recorded.
The subjects assigned to the normal hearing group will undertake 20min tACS stimulation applied over the temporo-parietal cortex. Each session will include the following three phases: (1) pre-stimulation baseline, (2) brain stimulation, and (3) post-stimulation. SAT will be conducted in each phase and concurrent EEG will be recorded.
The subjects assigned to the normal hearing group will undertake 20min sham stimulation applied over the temporo-parietal cortex. Each session will include the following three phases: (1) pre-stimulation baseline, (2) sham brain stimulation, and (3) post-stimulation. SAT will be conducted in each phase and concurrent EEG will be recorded.
The subjects assigned to the hearing impaired group will undertake 20min tACS stimulation applied over the temporo-parietal cortex. Each session will include the following three phases: (1) pre-stimulation baseline, (2) brain stimulation, and (3) post-stimulation. SAT will be conducted in each phase and concurrent EEG will be recorded.
The subjects assigned to the hearing impaired group will undertake 20min sham stimulation applied over the temporo-parietal cortex. Each session will include the following three phases: (1) pre-stimulation baseline, (2) sham brain stimulation, and (3) post-stimulation. SAT will be conducted in each phase and concurrent EEG will be recorded.
The subjects assigned to the tinnitus group will undertake 20min tACS stimulation applied over the temporo-parietal cortex. Each session will include the following three phases: (1) pre-stimulation baseline, (2) brain stimulation, and (3) post-stimulation. SAT will be conducted in each phase and concurrent EEG will be recorded.
The subjects assigned to the tinnitus group will undertake 20min sham stimulation applied over the temporo-parietal cortex. Each session will include the following three phases: (1) pre-stimulation baseline, (2) sham brain stimulation, and (3) post-stimulation. SAT will be conducted in each phase and concurrent EEG will be recorded.
Each participant of the normal hearing group will undergo the neurofeedback training in which the participants learn to increase alpha power in the right relative to the left parietal cortex. Before and after the NF training, participants will perform the AAT and concurrent EEG will be recorded.
Each participant of the normal hearing group will undergo the neurofeedback training in which the participants learn to increase alpha power in the left relative to the right parietal cortex. Before and after the NF training, participants will perform the AAT and concurrent EEG will be recorded.